ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

Service: Economic Modeling

In The News Pharmacoeconomic Modeling of Biosimilars in the US: A Conceptual Framework
In The News Financial implications of a hospital early mobility program
In The News An optimal voting procedure when voting is costly
In The News Cost-effectiveness of bronchial thermoplasty in commercially-insured patients with poorly controlled, severe, persistent asthma
In The News Cost-Effectiveness of Bronchial Thermoplasty in Patients with Poorly Controlled, Severe, Persistent Asthma
In The News Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States
In The News Cost Effectiveness of Treatments After Failure of a First-Line Hypomethylating Agent in Myelodysplastic Syndromes (MDS)
In The News Cost-effectiveness of Cetuximab as first-line treatment for metastatic colorectal cancer in the US
In The News Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer

Posts pagination

< Previous page 1 … 7 8 9 … 12 Next page >
© 2025
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health